| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
82,213 |
60,638 |
$5.75M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
108,819 |
76,860 |
$4.95M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
14,672 |
13,914 |
$2.06M |
| 96127 |
|
75,298 |
49,766 |
$1.06M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
8,784 |
7,474 |
$691K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,929 |
6,779 |
$567K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,956 |
3,777 |
$404K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
4,332 |
3,453 |
$353K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,970 |
3,435 |
$289K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,296 |
4,462 |
$227K |
| 99000 |
|
25,534 |
18,800 |
$227K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14,052 |
11,088 |
$172K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,280 |
1,862 |
$153K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,183 |
3,379 |
$104K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,175 |
2,444 |
$92K |
| 96136 |
|
2,579 |
2,248 |
$90K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
899 |
754 |
$61K |
| 99385 |
|
567 |
475 |
$60K |
| 99383 |
|
623 |
565 |
$58K |
| 0001A |
|
1,364 |
1,280 |
$56K |
| 99406 |
|
8,111 |
4,797 |
$55K |
| 0002A |
|
1,249 |
1,189 |
$52K |
| 99384 |
|
502 |
461 |
$51K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,389 |
2,211 |
$50K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,132 |
2,996 |
$50K |
| 80305 |
|
5,494 |
4,391 |
$48K |
| 94760 |
|
39,792 |
28,340 |
$47K |
| 90686 |
|
3,656 |
2,768 |
$46K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
331 |
323 |
$46K |
| 90734 |
|
2,747 |
2,244 |
$46K |
| 90651 |
|
2,546 |
2,110 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,832 |
2,334 |
$43K |
| 93000 |
|
1,947 |
1,573 |
$40K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
514 |
272 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,088 |
2,599 |
$37K |
| 80053 |
Comprehensive metabolic panel |
3,461 |
2,258 |
$34K |
| 99490 |
Ccm add 20min |
2,509 |
2,496 |
$34K |
| 82607 |
|
2,873 |
1,876 |
$32K |
| 90710 |
|
1,721 |
1,481 |
$30K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
651 |
386 |
$29K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
646 |
385 |
$28K |
| 99386 |
|
274 |
234 |
$28K |
| 99051 |
|
18,519 |
14,854 |
$27K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,851 |
1,861 |
$24K |
| 86060 |
|
2,885 |
1,878 |
$23K |
| 90715 |
|
2,020 |
1,686 |
$22K |
| 81002 |
|
8,576 |
6,807 |
$22K |
| 90670 |
|
1,896 |
1,608 |
$22K |
| 0003A |
|
532 |
290 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,481 |
2,291 |
$18K |
| 83690 |
|
2,763 |
1,807 |
$18K |
| 82150 |
|
2,849 |
1,856 |
$17K |
| 80061 |
Lipid panel |
2,963 |
1,947 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,129 |
2,090 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
11,514 |
9,769 |
$15K |
| 90723 |
|
1,604 |
1,388 |
$15K |
| 99381 |
|
144 |
123 |
$13K |
| 81025 |
|
3,679 |
2,832 |
$12K |
| 90619 |
|
735 |
666 |
$12K |
| 90648 |
|
1,617 |
1,376 |
$12K |
| 84550 |
|
2,873 |
1,874 |
$12K |
| 90633 |
|
1,180 |
1,037 |
$11K |
| 90620 |
|
687 |
572 |
$10K |
| 86696 |
|
538 |
282 |
$10K |
| 99215 |
Prolong outpt/office vis |
175 |
152 |
$10K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
664 |
635 |
$9K |
| 90700 |
|
1,086 |
933 |
$9K |
| 86803 |
|
592 |
315 |
$9K |
| 99382 |
|
85 |
75 |
$8K |
| 86695 |
|
537 |
281 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,095 |
5,187 |
$8K |
| 81001 |
|
2,786 |
1,674 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
242 |
96 |
$7K |
| 17110 |
|
94 |
64 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
689 |
453 |
$7K |
| 86705 |
|
518 |
270 |
$7K |
| 87340 |
|
583 |
317 |
$7K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
3,697 |
2,133 |
$6K |
| 99439 |
|
459 |
456 |
$6K |
| 0053A |
|
156 |
135 |
$6K |
| 90680 |
|
687 |
594 |
$6K |
| 87088 |
|
496 |
343 |
$6K |
| 87070 |
|
910 |
661 |
$5K |
| 87510 |
|
275 |
185 |
$5K |
| 87480 |
|
273 |
184 |
$5K |
| 0071A |
|
106 |
85 |
$4K |
| 90713 |
|
464 |
403 |
$4K |
| 90696 |
|
549 |
472 |
$4K |
| 0072A |
|
97 |
85 |
$4K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
272 |
257 |
$4K |
| 0124A |
|
99 |
74 |
$4K |
| 86140 |
|
750 |
485 |
$3K |
| 86038 |
|
205 |
140 |
$3K |
| 99201 |
|
104 |
71 |
$3K |
| 87660 |
|
273 |
185 |
$3K |
| 84481 |
|
289 |
199 |
$3K |
| 84702 |
|
374 |
231 |
$3K |
| 84439 |
|
308 |
209 |
$3K |
| 86709 |
|
527 |
274 |
$3K |
| 87186 |
|
212 |
142 |
$2K |
| 86580 |
|
561 |
429 |
$2K |
| 84153 |
|
202 |
139 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
68 |
65 |
$2K |
| 86225 |
|
200 |
136 |
$2K |
| 85610 |
|
576 |
319 |
$2K |
| 86592 |
|
535 |
281 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,130 |
1,893 |
$2K |
| 0052A |
|
55 |
48 |
$2K |
| 82043 |
|
504 |
291 |
$2K |
| 82570 |
|
448 |
288 |
$2K |
| 90716 |
|
161 |
133 |
$2K |
| 0012A |
|
44 |
44 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
27 |
26 |
$2K |
| 0011A |
|
45 |
44 |
$2K |
| 86431 |
|
213 |
142 |
$1K |
| 90707 |
|
110 |
97 |
$1K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
38 |
37 |
$953.25 |
| 99454 |
|
131 |
131 |
$864.39 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
192 |
153 |
$854.14 |
| 99457 |
|
117 |
117 |
$844.60 |
| 99497 |
|
85 |
85 |
$826.17 |
| 69210 |
|
38 |
30 |
$813.20 |
| 83704 |
|
45 |
22 |
$654.72 |
| 83698 |
|
46 |
23 |
$606.56 |
| 86141 |
|
46 |
23 |
$574.60 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
31 |
25 |
$570.21 |
| 85652 |
|
213 |
142 |
$547.82 |
| 87077 |
|
167 |
139 |
$539.85 |
| 0051A |
|
15 |
15 |
$509.37 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
31 |
29 |
$492.66 |
| 87147 |
|
148 |
98 |
$457.60 |
| 86901 |
|
95 |
58 |
$418.30 |
| 82172 |
|
46 |
23 |
$408.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14 |
12 |
$400.47 |
| 86850 |
|
75 |
44 |
$395.50 |
| 86900 |
|
96 |
59 |
$315.00 |
| 83695 |
|
46 |
23 |
$276.76 |
| 82728 |
|
39 |
25 |
$272.08 |
| 90744 |
|
44 |
39 |
$268.80 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
151 |
122 |
$265.74 |
| 3074F |
|
54,561 |
40,530 |
$258.49 |
| 85730 |
|
46 |
26 |
$217.56 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$174.00 |
| 3008F |
|
130,527 |
94,911 |
$167.78 |
| 3078F |
|
41,420 |
31,697 |
$166.71 |
| H0049 |
Alcohol and/or drug screening |
12 |
12 |
$120.96 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
33 |
28 |
$90.01 |
| 3079F |
|
22,831 |
17,195 |
$88.77 |
| 99442 |
|
39 |
33 |
$60.25 |
| 91300 |
|
1,861 |
1,557 |
$50.40 |
| 3075F |
|
8,996 |
6,948 |
$35.22 |
| 3077F |
|
6,475 |
4,811 |
$25.48 |
| 3080F |
|
5,560 |
4,211 |
$21.66 |
| 91301 |
|
64 |
64 |
$0.47 |
| 91305 |
|
197 |
168 |
$0.11 |
| 91307 |
|
192 |
146 |
$0.05 |
| 1090F |
|
78 |
65 |
$0.00 |
| 3725F |
|
279 |
238 |
$0.00 |
| 1160F |
|
66 |
54 |
$0.00 |
| 1159F |
|
66 |
54 |
$0.00 |
| 4004F |
|
107 |
97 |
$0.00 |
| 3288F |
|
66 |
53 |
$0.00 |
| 1034F |
|
111 |
98 |
$0.00 |
| 1170F |
|
280 |
239 |
$0.00 |
| 1031F |
|
66 |
53 |
$0.00 |
| 99458 |
|
24 |
24 |
$0.00 |
| 1111F |
|
67 |
54 |
$0.00 |